Article Versions Notes

Kojima Y, Nakakubo S, Takei N, Kamada K, Yamashita Y, Nakamura J, Matsumoto M, Horii H, Sato K, Shima H, et al. Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study. Medicina. 2022; 58(4):513. https://doi.org/10.3390/medicina58040513

Kojima, Yuichi, Sho Nakakubo, Nozomu Takei, Keisuke Kamada, Yu Yamashita, Junichi Nakamura, Munehiro Matsumoto, Hiroshi Horii, Kazuki Sato, Hideki Shima, and et al. 2022. "Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study" Medicina 58, no. 4: 513. https://doi.org/10.3390/medicina58040513

Kojima, Y., Nakakubo, S., Takei, N., Kamada, K., Yamashita, Y., Nakamura, J., Matsumoto, M., Horii, H., Sato, K., Shima, H., Suzuki, M., & Konno, S. (2022). Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study. Medicina, 58(4), 513. https://doi.org/10.3390/medicina58040513